Heparin is an injectable blood thinner, utilized for the treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is also employed as part of the treatment of unstable angina and myocardial infarction. The increasing incidence of coagulation disorders is propelling the demand for heparin significantly across the world.
The global heparin market has been analyzed on the basis of product in this research report. Ultra-low molecular weight heparin (ULMWHs), low molecular weight heparin (LMWHs), and unfractionated heparin are the major products available in the worldwide heparin market. ULMWHs has been the most commonly used heparin over the past decade. However, the increasing overall cost of ULMWHs is likely to hamper the growth of this market segment in the near future, states the research report.
Inquire for Sample Copy of this Study – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803
North America Reports Highest Demand for Heparin Due to Rising Prevalence of Coagulation Disorders
Regionally, North America emerged as the largest market for heparin products in 2014. As per the Centers of Disease Control and Prevention (CDC), nearly 900,000 people in the U.S. are affected by DVT and PE every year. Moreover, due to the sophisticated healthcare infrastructure the country boasts, the U.S. is visited by an increasing number of medical tourists annually. The overall number of surgical procedures conducted in the country is thus comparatively higher. This fuels demand for heparin products from North America. TMR projects the North America heparin market to rise at a CAGR of 6.3% between 2014 and 2023.
Europe emerged as the second largest market for heparin products in the same year. The U.K., Germany, and France are the most lucrative markets for heparin in the region. However, as per Transparency Market Research, the heparin market in Asia Pacific is expected to exhibit the fastest growth during the forecast period. The incidence of VTE has nearly doubled in India in the last decade.
Despite economic growth witnessed across the emerging nations of Asia Pacific, the unavailability of appropriate diagnostic centers and lack of awareness are leading to a lesser number of cases of DVT being reported. Nevertheless, GDP growth, increasing spending in healthcare infrastructure, and rising geriatric population are expected to fuel demand for heparin from Asia Pacific in the forthcoming years.
Get Discount on Report Purchase – http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=803
Low Molecular Weight Heparins Emerge as Standard Choice of Drug Care for Arterial and Venous Thrombosis
The most commonly used heparin products include ultra-low molecular weight heparin (ULMWH), low molecular weight heparin (LMWH), and unfractionated heparin. Although the demand for LMWHs is higher, the choice of heparin depends on the disease and patient’s condition. Low molecular weight heparins offer proven benefits over unfractionated heparins, due to which the demand for the former is rising at a higher pace.
Currently, LMWHs are considered the standard choice of care drugs for the treatment of arterial and venous thrombosis. This category of heparins also exhibits comparatively lesser side-effects, which is expected to bolster their sales in the forthcoming years. According to TMR, the LMWHs segment is expected to reach US$12.3 bn by the end of 2023. Demand from the ULMWHs segment is expected increase due to the rising use of these anticoagulants as an alternative to unfractionated heparin in dialysis.
Some of the leading players operating in the market are Fresenius Kabi AG, Dr. Reddy’s Laboratories Ltd., Mylan N.V., LEO Pharma A/S, Pfizer, Inc., Syntex S.A., Sanofi S.A., and Teva Pharmaceutical Industries Ltd.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453